SinoMab completes subscription of new shares under general mandate

SinoMab BioScience Limited (HKEX: 3681) announced the completion of subscriptions for new shares under its general mandate, effective May 29, 2025. The company issued an aggregate of 112,810,817 shares at a subscription price of HKD 1.10 per share. This represents approximately 10.33% of the company's issued share capital immediately before the completion and around 9.37% after the issue. The subscriptions generated net proceeds of approximately HKD 123,956,911, to be applied as previously disclosed. Following the completion, the company's shareholding structure has been updated, with existing major shareholders' percentages adjusted accordingly.